Page 165 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 165
TOP 10% TRANSENDOTHELIAL MIGRATION DEPENDS ePOSTERS
YI P0259 ON TRANSFORMING GROWTH FACTOR BETA IN
YI P0260 HEPATOCELLULAR CARCINOMA PROGRESSION
Petra Koudelkova*, Gerhard Weber, Steven Dooley, Victor Costina,
YI P0261 Peter Findeisen, Wolfgang Mikulits, Austria
YI P0262
LIVER KINASE B1 AS AN ONCOGENIC DRIVER IN LIVER
YI P0263 CANCER
YI P0264 Juan L. García-Rodríguez, Imanol Zubiete-Franco*, David Fernández-
Ramos, Pablo Fernández-Tussy, Lucía Barbier-Torres, Fernando Lopitz-
Otsoa, Virginia Gutiérrez-de Juan, César Martín-Plágaro,
Patricia Aspichueta, Loreto Boix, Jordi Bruix, Diego F. Calvisi,
Marta Varela-Rey, Mario F. Fraga, Naiara Beraza, Shelly C. Lu,
José M. Mato, Teresa C. Delgado, María L. Martínez-Chantar, Spain
A GLOBAL RISK GENE SCORE PREDICTS EARLY AND
LATE TUMOR RECURRENCE AFTER RESECTION OF
HEPATOCELLULAR CARCINOMA
Jeroen Dekervel*, Dusan Popovic, Hannah van Malenstein,
Petra Windmolders, Louis Libbrecht, Ashenafi Bulle, Bart De Moor,
Eric Van Cutsem, Frederik Nevens, Chris Verslype, Jos van Pelt, Belgium
INHIBITION OF REGULATORY T CELLS USING THE FOXP3-
INHIBITORY PEPTIDE P60 IMPROVES ANTITUMOURAL
EFFECT OF A VACCINATION WITH MAFP-EXPRESSING
DC IN SUBCUTANEOUS AND ORTHOTOPIC MURINE HCC
MODEL
Julia Waysczak*, Annabelle Vogt, Noelia Casares,
Juan J. Lasarte, Jesús Prieto, Ingo Schmidt-Wolf, Christian P. Strassburg,
Maria A. Gonzalez-Carmona, Germany
CONSEQUENCES OF B-CATENIN PATHWAY ACTIVATION
ON MOUSE HEPATIC METABOLISM
Nadia Senni*, Angélique Gougelet, Chiara Sartor, Christine Perret,
Sabine Colnot, Pascale Bossard, France
REDIRECTING ADENOVIRUS-SPECIFIC T CELLS BY A
TUMOR-SPECIFIC T CELL RECEPTOR FOR THERAPY OF
HEPATOCELLULAR CARCINOMA
Cristina I. Ureche*, Engin Guerlevik, Norman Woller,
Bettina Fleischmann-Mundt, Arnold Kloos, Michael P. Manns,
Stefan Kubicka, Florian Kuehnel, Germany
Vienna, Austria • April 22–26, 2015 165
YI P0259 ON TRANSFORMING GROWTH FACTOR BETA IN
YI P0260 HEPATOCELLULAR CARCINOMA PROGRESSION
Petra Koudelkova*, Gerhard Weber, Steven Dooley, Victor Costina,
YI P0261 Peter Findeisen, Wolfgang Mikulits, Austria
YI P0262
LIVER KINASE B1 AS AN ONCOGENIC DRIVER IN LIVER
YI P0263 CANCER
YI P0264 Juan L. García-Rodríguez, Imanol Zubiete-Franco*, David Fernández-
Ramos, Pablo Fernández-Tussy, Lucía Barbier-Torres, Fernando Lopitz-
Otsoa, Virginia Gutiérrez-de Juan, César Martín-Plágaro,
Patricia Aspichueta, Loreto Boix, Jordi Bruix, Diego F. Calvisi,
Marta Varela-Rey, Mario F. Fraga, Naiara Beraza, Shelly C. Lu,
José M. Mato, Teresa C. Delgado, María L. Martínez-Chantar, Spain
A GLOBAL RISK GENE SCORE PREDICTS EARLY AND
LATE TUMOR RECURRENCE AFTER RESECTION OF
HEPATOCELLULAR CARCINOMA
Jeroen Dekervel*, Dusan Popovic, Hannah van Malenstein,
Petra Windmolders, Louis Libbrecht, Ashenafi Bulle, Bart De Moor,
Eric Van Cutsem, Frederik Nevens, Chris Verslype, Jos van Pelt, Belgium
INHIBITION OF REGULATORY T CELLS USING THE FOXP3-
INHIBITORY PEPTIDE P60 IMPROVES ANTITUMOURAL
EFFECT OF A VACCINATION WITH MAFP-EXPRESSING
DC IN SUBCUTANEOUS AND ORTHOTOPIC MURINE HCC
MODEL
Julia Waysczak*, Annabelle Vogt, Noelia Casares,
Juan J. Lasarte, Jesús Prieto, Ingo Schmidt-Wolf, Christian P. Strassburg,
Maria A. Gonzalez-Carmona, Germany
CONSEQUENCES OF B-CATENIN PATHWAY ACTIVATION
ON MOUSE HEPATIC METABOLISM
Nadia Senni*, Angélique Gougelet, Chiara Sartor, Christine Perret,
Sabine Colnot, Pascale Bossard, France
REDIRECTING ADENOVIRUS-SPECIFIC T CELLS BY A
TUMOR-SPECIFIC T CELL RECEPTOR FOR THERAPY OF
HEPATOCELLULAR CARCINOMA
Cristina I. Ureche*, Engin Guerlevik, Norman Woller,
Bettina Fleischmann-Mundt, Arnold Kloos, Michael P. Manns,
Stefan Kubicka, Florian Kuehnel, Germany
Vienna, Austria • April 22–26, 2015 165
